| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT06008288 | A Phase II Study Evaluating JAB-21822 Monotherapy in Adult Patients With Pancreatic… | KRAS P.G12C | Recruiting |
| NCT06563999 | Neoadjuvant Umbrella Trial for Patients With Unresectable Stage III NSCLC Harboring Rare… | Lung Cancer Stage III | Recruiting |
| Phase 1/2 | |||
| NCT07339839 | Glecirasib Combined With Ivonescimab for First-line Treatment of KRAS G12C-mutated NSCLC | NSCLC Stage IV | Not Yet Recruiting |
| NCT05009329 | A Study of JAB-21822 in Adult Patients With Advanced Solid Tumors Harboring KRAS p.G12C… | NSCLC | Active, Not Recruiting |
| NCT05194995 | JAB-21822 in Combination With Cetuximab in Patients With Advanced CRC and Other Solid… | Advanced Colorectal Cancer | Active, Not Recruiting |
| Phase 1 | |||
| NCT06838338 | JAB-21822 Combined With Chemotherapy and Bevacizumab in Second-line KRAS G12C CRC | Colorectal Cancer | Active, Not Recruiting |